Table 1 Baseline characteristics of the study population
Variables | Whole population n = 1743 |
|---|---|
Age [years (mean ± SD)] | 43 ± 3 |
Male gender [n (%)] | 814 (46) |
SAPS II score, points (mean ± SD) | 34 ± 17 |
Mental disorder [n (%)] | |
Schizophrenia | 97 (6) |
Non-schizophrenia psychiatric disorder | 237 (13) |
Depression disorder | 1058 (60) |
Bipolar disorder | 172 (10) |
Anxiety disorder | 187 (11) |
Substance dependence (alcohol and/or drug addiction) | 492 (28) |
Transfer from psychiatric hospital or ward [n (%)] | 130 (7) |
Psychoactive medication before admission [n (%)] | |
None | 197 (11) |
Benzodiazepines | 1043 (60) |
Neuroleptics | 497 (28) |
Antipsychotics other than neuroleptics | 175 (10) |
Lithium | 81 (5) |
SSRIs | 420 (24) |
SNRIs | 34 (2) |
Tri- or tetracyclics antidepressants | 226 (13) |
MAOIs | 148 (8) |
Admission following deliberate self-harm [n (%)] | 1280 (73) |
Deliberate self-poisoning with psychoactive medications | |
Alone | 1082 (62) |
And/or with non-psychoactive medications | 139 (8) |
And/or with pesticides, household, or industrial products | 28 (1.5) |
And/or with hanging, drowning, jumping from buildings, or corrosive chemicals ingestion | 31 (1.5) |
Admission for another reason than deliberate self-harm | 463 (27) |
Respiratory failure | 165 (9) |
Shock | 65 (4) |
CNS or peripheral disorder | 82 (5) |
Metabolic disorder | 53 (3) |
Out-of-hospital cardiac arrest | 18 (1) |
Acute kidney injury | 13 (0.5) |
Non-deliberate psychoactive medication overdose | 44 (2.5) |
Miscellaneous | 33 (2) |
Chemical pneumonitis and/or aspiration pneumonia [n (%)] | 479 (27) |
Organ support in the ICU [n (%)] | |
Invasive mechanical ventilation | 1206 (69) |
Vasopressors | 378 (22) |
Renal replacement therapy | 176 (10) |
ICU outcomes [n (%)] | |
Acquired infection at any site | 64 (4) |
Mortality | 91 (5) |